Reduction and oxidation (Redox) are defined by the gain and loss of electrons, respectively, both of which affect the structure and function of proteins. Cardiac stress increases reactive oxygen species (ROS), which oxidize proteins, thereby affecting a wide variety of cellular functions, including hypertrophy and cell death. Thioredoxin1 (Trx1) is a 12 kD protein that protects the heart from pathological hypertrophy and ischemia/reperfusion. Trx1 interacts with intracellular signaling molecules, and reduces oxidized cysteine residues, thereby modulating their function. Our long-term goal is to identify important substrates of Trx1 in the heart and elucidate the functional significance of the regulatory effect of Trx1 in response to clinically relevant stress. In order to identify novel targets of Trx1 durin myocardial ischemia, we generated transgenic mice with cardiac specific expression of a Trx1 trap mutant. One of the proteins we identified using this system was AMP-activated protein kinase (AMPK), a serine threonine kinase. AMPK is an important sensor of energy stress and positively regulates the catabolic process to maintain the energy level. We hypothesize that AMPK is subjected to cysteine oxidation during myocardial ischemia, which negatively regulates AMPK. Trx1 is an essential co-factor of AMPK, allowing AMPK to be activated during myocardial ischemia to promote cell survival by reducing the oxidized cysteines in AMPK. AMPK and Trx1 form a positive feedback loop to stimulate one another's functions during stress. We will: 1) elucidate the molecular mechanism by which cysteine oxidation during ischemia inactivates AMPK, 2) demonstrate the role of Trx1 as an essential co-factor of AMPK during myocardial ischemia, and 3) demonstrate that AMPK and Trx1 form a positive feedback mechanism to protect the heart against ischemia, but that their function is impaired in response to consumption of a high fat diet. We will use proteomic analyses of posttranslational modifications and unique genetically altered mouse models. Our study will elucidate how posttranslational oxidative modification of cysteine residues regulates the activity of AMPK during metabolic stress and show that Trx1 is a critical co-factor of AMPK in the protection of the heart against prolonged ischemia.

Public Health Relevance

We will elucidate the molecular mechanisms by which oxidative stress modulates the functions of intracellular signaling molecules during myocardial ischemia and their functional significance. In particular, AMP-dependent protein kinase (AMPK), a molecule that acts as a fuel gauge in the heart, and thioredoxin 1 (Trx1), an anti- oxidant, stimulate one another's actions to protect the heart during myocardial ischemia. The cooperative function of the two molecules is attenuated by oxidative stress. We will investigate how the synergistic action of the two molecules can be restored during ischemia. Our study may provide an important clue as to how to develop a novel strategy to treat ischemic heart disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL091469-08
Application #
8607979
Study Section
Cardiac Contractility, Hypertrophy, and Failure Study Section (CCHF)
Program Officer
Schwartz, Lisa
Project Start
2008-01-15
Project End
2018-02-28
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
8
Fiscal Year
2014
Total Cost
$522,264
Indirect Cost
$193,796
Name
Rutgers University
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
078795851
City
Newark
State
NJ
Country
United States
Zip Code
07103
Maejima, Yasuhiro; Chen, Yun; Isobe, Mitsuaki et al. (2015) Recent progress in research on molecular mechanisms of autophagy in the heart. Am J Physiol Heart Circ Physiol 308:H259-68
Matsushima, Shouji; Tsutsui, Hiroyuki; Sadoshima, Junichi (2014) Physiological and pathological functions of NADPH oxidases during myocardial ischemia-reperfusion. Trends Cardiovasc Med 24:202-5
Yamamoto, Takanobu; Byun, Jaemin; Zhai, Peiyong et al. (2014) Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion. PLoS One 9:e98972
Maejima, Yasuhiro; Sadoshima, Junichi (2014) SUMOylation: a novel protein quality control modifier in the heart. Circ Res 115:686-9
Maejima, Yasuhiro; Usui, Soichiro; Zhai, Peiyong et al. (2014) Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A. Circ Heart Fail 7:479-90
Sciarretta, Sebastiano; Yee, Derek; Shenoy, Varun et al. (2014) The importance of autophagy in cardioprotection. High Blood Press Cardiovasc Prev 21:21-8
Sciarretta, Sebastiano; Volpe, Massimo; Sadoshima, Junichi (2014) Mammalian target of rapamycin signaling in cardiac physiology and disease. Circ Res 114:549-64
Del Re, Dominic P; Matsuda, Takahisa; Zhai, Peiyong et al. (2014) Mst1 promotes cardiac myocyte apoptosis through phosphorylation and inhibition of Bcl-xL. Mol Cell 54:639-50
Shao, Dan; Oka, Shin-Ichi; Liu, Tong et al. (2014) A redox-dependent mechanism for regulation of AMPK activation by Thioredoxin1 during energy starvation. Cell Metab 19:232-45
Yu, Qiujun; Lee, Chi Fung; Wang, Wang et al. (2014) Elimination of NADPH oxidase activity promotes reductive stress and sensitizes the heart to ischemic injury. J Am Heart Assoc 3:e000555

Showing the most recent 10 out of 74 publications